Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$5.65B
sum of reported positions
Reported positions
543
Changes vs prior quarter
567
60 new · 52 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 344 measured positions in 8 quarters, the typical new or larger position finished −1.0 pts against the S&P 500 and 48% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 592K | $72.4M | 1.3% | |
| 109K | $62.8M | 1.1% | |
| 652K | $62.7M | 1.1% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.

Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $4.72B | $5.65B |
| Positions | 535 | 543 |
| Biggest line | — | Mercury Systems 1% |
| 848K |
| $62.4M |
| 1.1% |
| 565K | $55M | 1.0% |
| 690K | $48M | 0.8% |
| 659K | $47.7M | 0.8% |
| 1.58M | $47.2M | 0.8% |
| 611K | $46.4M | 0.8% |
| 1.63M | $45.7M | 0.8% |
| 149K | $44.2M | 0.8% |
| 545K | $42.7M | 0.8% |
| 112K | $42.4M | 0.7% |
| 426K | $41.5M | 0.7% |
| 172K | $40.1M | 0.7% |
| 357K | $40.1M | 0.7% |
| 234K | $37.6M | 0.7% |
| 540K | $37.6M | 0.7% |
| 227K | $37.3M | 0.7% |
| 601K | $36.8M | 0.7% |
| 230K | $35.7M | 0.6% |
| 345K | $34.4M | 0.6% |
| 660K | $34.4M | 0.6% |
| 670K | $34.3M | 0.6% |
| 479K | $33.4M | 0.6% |
Northern Oil and Gas, Inc. (NOG)
929K → 794K shares (−15%)
UGI Corp (UGI)
424K → 412K shares (−3%)
Five Star Bancorp (FSBC)
378K → 292K shares (−23%)
Upbound Group, Inc. (UPBD)
669K → 652K shares (−3%)
AAON (AAON)
160K → 109K shares (−32%)
MKS Instruments (MKSI)
37K → 31K shares (−16%)
Mesa Laboratories Inc (MLAB)
142K → 138K shares (−3%)
Enterprise Financial Services (EFSC)
215K → 209K shares (−3%)
Qnity Electronics (Q)
123K → 84K shares (−32%)
Cogent Biosciences (COGT)
360K → 354K shares (−2%)
Johnson & Johnson (JNJ)
57K → 54K shares (−5%)
Trimas (TRS)
377K → 302K shares (−20%)
Natures Sunshine Products (NATR)
691K → 624K shares (−10%)
Plexus Corp. (PLXS)
77K → 44K shares (−43%)
Carter Bankshares (CARE)
450K → 384K shares (−15%)
Celldex Therapeutics (CLDX)
352K → 342K shares (−3%)
Ryman Hospitality Properties (RHP)
103K → 98K shares (−4%)
Cushman & Wakefield (CWK)
966K → 938K shares (−3%)
Universal Technical Institute (UTI)
307K → 292K shares (−5%)
Edwards Lifesciences (EW)
144K → 138K shares (−4%)
Installed Building Products, Inc. (IBP)
55K → 53K shares (−4%)
Avista Corporation (AVA)
301K → 293K shares (−3%)
BankUnited, Inc. (BKU)
253K → 246K shares (−3%)
V2X, Inc. (VVX)
162K → 159K shares (−2%)
Astronics (ATRO)
144K → 141K shares (−2%)